Suven Life Sciences Ltd. | Cash Flow
Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,027
1,516
976
1,231
1,955
Depreciation, Depletion & Amortization
115
242
240
276
248
Other Funds
410
379
426
544
617
Funds from Operations
1,733
1,379
790
963
1,586
Changes in Working Capital
573
82
144
79
924
Net Operating Cash Flow
1,160
1,461
646
1,042
662
Capital Expenditures
379
1,183
579
305
418
Sale of Fixed Assets & Businesses
-
-
-
-
-
Purchase/Sale of Investments
-
-
162
2,811
403
Net Investing Cash Flow
378
1,183
416
3,117
15
Cash Dividends Paid - Total
41
342
398
153
230
Issuance/Reduction of Debt, Net
265
179
218
94
301
Net Financing Cash Flow
306
1,838
617
247
531
Net Change in Cash
476
2,117
387
2,322
117
Free Cash Flow
781
278
67
747
262
Change in Capital Stock
-
2,000
-
-
-
About Suven Life Sciences
View Profile
